Dr. Douglas Scharre is the director of the Division of Cognitive Neurology and co-director of the Neuroscience Research Institute at The Ohio State University Wexner Medical Center. He is a board-certified neurologist with special interests in degenerative dementias and dementia-related behaviors.
Over the last 20 years, Dr. Scharre has conducted over 130 dementia related clinical trials funded by NIH, foundations, and industry. He has published multiple journal papers, book chapters, and abstracts in the area of cognitive neurology. He lectures frequently on topics of dementia, Alzheimer's disease, behavioral management of dementia, and other aspects of cognitive neurology. Dr. Scharre also developed the Self-Administered Gerocognitive Examination (SAGE) to help identify individuals with mild thinking and memory impairments at an early stage.